TOP STORIES

• REGULATORY Chuikyo OKs Outline of FY2016 Drug Pricing Reform
  December 25, 2015

• REGULATORY Plavix, 15 Other Brands to Lose Premiums on Generic, Biosimilar Entries; Re-Pricing Could Deal Another Blow
  December 24, 2015

• REGULATORY Drug Prices to Be Pared 7.8% If Re-Pricing, Z2, Generic Price Cuts Included
  December 22, 2015

• REGULATORY Govt to Shed 28 Bil. Yen via Huge Seller Drugs, 20 Bil. Yen via Existing Re-Pricing Rule; Physicians to Win “Plus” Revision
  December 21, 2015

• REGULATORY ICH Reaches Agreement to Treat Subjects with Similar Ethnic Factors as Single Populations Regardless of Nationality
  December 18, 2015

• REGULATORY Survey Finds Unexpectedly Low Market Prices for Injectable Generics; Industry to Accept 50% Rule
  December 17, 2015

• REGULATORY Chuikyo Subcommittee OKs Outline of FY2016 Drug Pricing Reform, Rollout of “Huge Seller” Re-Pricing
  December 17, 2015

• BUSINESS LEO Pharma “Eager to Do More” after Astellas Deal to Expand Globally: CEO
  December 16, 2015

• BUSINESS Mundipharma Poised to Expand Japan Operations by Tapping Isodine Brand: Asia Head
  December 15, 2015

• ORGANIZATION PhRMA Sounds Alarm on “Huge Seller” Re-Pricing, Possible Decline in Japan Investment
  December 14, 2015

• REGULATORY 6 Drug Makers to Participate in AMED’s Drug Discovery Consortium
  December 11, 2015

• REGULATORY 3 Trade Groups Vehemently Oppose “Huge Seller” Drug Re-Pricing, Say It Will Hobble Innovation
  December 10, 2015

• TRENDS “Huge Seller” Re-Pricing Targeting Hep C Drugs Will Dampen Innovative Market
  December 9, 2015

• REGULATORY LDP Budget Debate in Homestretch; Govt Eyes “Huge Sellers”, Generics, Z2 to Squeak Out Funds for Upping Physician Fees
  December 9, 2015

• REGULATORY PMDA to Begin Unannounced Regular Inspections in Wake of GMP Violations by Kaketsuken
  December 8, 2015

• TRENDS Peak Sales Forecast for New Drugs Listed in 2015 Exceeded 840 Billion Yen with Big Contribution from Hep C Treatments
  December 7, 2015

• BUSINESS Unusualness of Hep C Market Not Being Understood, Gilead COO Says on Possible Sovaldi Re-Pricing
  December 4, 2015

• REGULATORY Probe Finds Kaketsuken’s GMP Violations “Extremely Malicious”, MHLW to Impose Penalty
  December 3, 2015

• REGULATORY NHI-Market Price Gap at 8.8%, 6.8% Price Cut Expected in FY2016 Revision
  December 3, 2015

• REGULATORY MHLW Discussing Use of Disease Registry as Substitute for Control Groups; Could Be “One Means of Evaluation” in Trials for Rare Diseases
  December 2, 2015

ページ

• « 先頭
• ‹ Prev
• …
• 176
• 177
• 178
• 179
• 180
• 181
• 182
• 183
• 184
• …
• Next ›
• 最終 »